Clinical Trial

A Phase 2 Study of HSK47388 Tablets to Evaluate the Efficacy and Safety in Patients With Moderate-to-Severe Plaque Psoriasis

Name: A Phase 2 Study of HSK47388 Tablets to Evaluate the Efficacy and Safety in Patients With Moderate-to-Severe Plaque Psoriasis — clinical trial record (NCT07158268)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The primary objective of this study is to evaluate the efficacy of multiple-dose HSK47388 versus placebo in participants with moderate-to-severe plaque psoriasis.

Trial Details

NCT Number	NCT07158268
Lead Sponsor	Haisco Pharmaceutical Group Co., Ltd.
Conditions	Plaque Psoriasis
Enrollment	220 participants
Start Date	2025-09-01
Primary Completion	2026-12-20 (estimated)
Study Completion	2027-01-17 (estimated)
Updated on ClinicalTrials.gov	2025-09-05